Duan Xiao-hong, Dong Jing-cheng, He Li-qun
Huashan Hospital of Fudan University, Shanghai 200040.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011 Jun;31(6):765-8.
To observe the effect of Bushen Huoxue Recipe (BSHXR, a Chinese medicine recipe for Shen reinforcing and blood circulation activating) on the levels of urinary albumin, interleukin-6 (IL-6), transforming growth factor-beta1 (TGF-beta1), and monocyte chemotactic protein-1 (MCP-1) in chronic nephritis patients of Shen-deficiency blood-stasis syndrome.
Forty-five patients were blocking assigned randomly to two groups, fifteen patients in the control group and thirty in the treatment group. All orally took Monopril 10 mg, once daily. But BSHXR was given additionally to patients in the treatment group after decocting,one dose per day (taken in two times). The treatment course for both groups was eight weeks. Besides, a normal control group consisting of six healthy subjects from health examination of Shuguang Hospital was set up. The 24-h urinary albumin and contents of TGF-beta1, IL-6 and MCP-1 in urine of all subjects were observed.
Compared with before treatment the 24-h urinary albumin was obviously reduced in the treatment group, showing significant difference (P<0.01). The urinary 24-h albumin decreased in the control group, with statistical significance (P<0.05). Statistical difference existed between the treatment group and the control group after treatment (P<0.01). Compared with before treatment, urinary levels of IL-6, TGF-beta1, and MCP-1 were all down-regulated in the treatment group and the control group after treatment (P<0.01), and the decreasing of IL-6 and TGF-beta1, levels was more significant in the treatment group statistically (P<0.05).
BSHXR could attenuate the albuminuria in patients of chronic nephritis. Its mechanism might be possibly correlated with its down-regulation of IL-6, TGF-beta1, and MCP-1 levels.
观察补肾活血方对慢性肾炎肾虚血瘀证患者尿白蛋白、白细胞介素-6(IL-6)、转化生长因子-β1(TGF-β1)及单核细胞趋化蛋白-1(MCP-1)水平的影响。
45例患者随机分为两组,对照组15例,治疗组30例。两组均口服蒙诺10 mg,每日1次。治疗组在此基础上加服补肾活血方水煎剂,每日1剂(分2次服用)。两组疗程均为8周。此外,设立正常对照组,选取曙光医院健康体检的6名健康受试者。观察所有受试者24小时尿白蛋白及尿中TGF-β1、IL-6和MCP-1含量。
与治疗前比较,治疗组24小时尿白蛋白明显降低,差异有统计学意义(P<0.01)。对照组24小时尿白蛋白也有所降低,差异有统计学意义(P<0.05)。治疗后治疗组与对照组比较,差异有统计学意义(P<0.01)。与治疗前比较,治疗组和对照组治疗后尿中IL-6、TGF-β1、MCP-1水平均下调(P<0.01),且治疗组IL-6和TGF-β1水平下降更明显,差异有统计学意义(P<0.05)。
补肾活血方可减轻慢性肾炎患者蛋白尿。其机制可能与下调IL-6、TGF-β1、MCP-1水平有关。